Study of visual and anatomical outcomes of aflibercept in good visual acuity baseline of wet age-related macular degeneration

Trial Profile

Study of visual and anatomical outcomes of aflibercept in good visual acuity baseline of wet age-related macular degeneration

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Sep 2015

At a glance

  • Drugs Aflibercept (Primary)
  • Indications Wet age-related macular degeneration
  • Focus Therapeutic Use
  • Sponsors Bayer Yakuhin
  • Most Recent Events

    • 22 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by University Medical Information Network-Japan record.
    • 06 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top